{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:08:02Z","timestamp":1784542082768,"version":"3.55.0"},"reference-count":44,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["21-75-30003"],"award-info":[{"award-number":["21-75-30003"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The emergence of the new coronavirus SARS-CoV-2 in late 2019 led to the global pandemic COVID-19, causing a profound socioeconomic crisis. Adequate diagnostic tools need to be developed to control the ongoing spread of infection. Virus-specific humoral immunity in COVID-19 patients and those vaccinated with specific vaccines has been characterized in numerous studies, mainly using Spike protein-based serology tests. However, Spike protein and specifically its receptor-binding domain (RBD) are mutation-prone, suggesting the reduced sensitivity of the validated serology tests in detecting antibodies raised to variants of concern (VOC). The viral nucleocapsid (N) protein is more conserved compared to Spike, but little is known about cross-reactivity of the N-specific antibodies between the ancestral B.1 virus and different VOCs. Here, we generated recombinant N phosphoproteins from different SARS-CoV-2 strains and analyzed the magnitude of N-specific antibodies in COVID-19 convalescent sera using an in-house N-based ELISA test system. We found a strong positive correlation in the magnitude of anti-N (B.1) antibodies and antibodies specific to various VOCs in COVID-19-recovered patients, suggesting that the N-binding antibodies are highly cross-reactive, and the most immunogenic epitopes within this protein are not under selective pressure. Overall, our study suggests that the RBD-based serology tests should be timely updated to reflect the constantly evolving nature of the SARS-CoV-2 Spike protein, whereas the validated N-based test systems can be used for the analysis of sera from COVID-19 patients regardless of the strain that caused the infection.<\/jats:p>","DOI":"10.3390\/v14092041","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T01:48:10Z","timestamp":1663206490000},"page":"2041","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5552-9874","authenticated-orcid":false,"given":"Alexandra","family":"Rak","sequence":"first","affiliation":[{"name":"Institute of Experimental Medicine, Saint Petersburg 197022, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Donina","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, Saint Petersburg 197022, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2012-9461","authenticated-orcid":false,"given":"Yana","family":"Zabrodskaya","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, Saint Petersburg 197022, Russia"},{"name":"Smorodintsev Research Institute of Influenza, Saint Petersburg 197376, Russia"},{"name":"Institute of Biomedical Systems and Biotechnology, Peter the Great Saint Petersburg Polytechnic University, Saint Petersburg 194064, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, Saint Petersburg 197022, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-9959","authenticated-orcid":false,"given":"Irina","family":"Isakova-Sivak","sequence":"additional","affiliation":[{"name":"Institute of Experimental Medicine, Saint Petersburg 197022, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"ref_2","unstructured":"(2022, June 13). Worldometer of COVID-19 Coronavirus Pandemic. Available online: https:\/\/www.worldometers.info\/coronavirus\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e00228-20","DOI":"10.1128\/CMR.00228-20","article-title":"Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)\/COVID-19 Detection","volume":"34","author":"LeBlanc","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S1473-3099(20)30517-X","article-title":"Serology testing in the COVID-19 pandemic response","volume":"20","author":"Peeling","year":"2020","journal-title":"Lancet. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2002411","DOI":"10.1183\/13993003.02411-2020","article-title":"The value of serology testing to manage SARS-CoV-2 infections","volume":"56","author":"Torres","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Upreti, S., and Samant, M. (2022). A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens. Pharm. Res.","DOI":"10.1007\/s11095-022-03323-w"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/22221751.2021.1913973","article-title":"Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort","volume":"10","author":"Rockstroh","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e142386","DOI":"10.1172\/jci.insight.142386","article-title":"Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity","volume":"5","author":"McAndrews","year":"2020","journal-title":"JCI Insight"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e0024721","DOI":"10.1128\/Spectrum.00247-21","article-title":"Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: A Head-to-Head Comparison of Five Quantitative Assays","volume":"9","author":"Perkmann","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"(2022). Evolutionary insight into the emergence of SARS-CoV-2 variants of concern. Nat. Med., 28, 1357\u20131358.","DOI":"10.1038\/s41591-022-01892-2"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1080\/21645515.2015.1010859","article-title":"H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers","volume":"11","author":"Stukova","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1016\/j.vaccine.2015.08.019","article-title":"Clinical testing of pre-pandemic live attenuated A\/H5N2 influenza candidate vaccine in adult volunteers: Results from a placebo-controlled, randomized double-blind phase I study","volume":"33","author":"Rudenko","year":"2015","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Matyushenko, V., Isakova-Sivak, I., Kudryavtsev, I., Goshina, A., Chistyakova, A., Stepanova, E., Prokopenko, P., Sychev, I., and Rudenko, L. (2021). Detection of IFNgamma-Secreting CD4(+) and CD8(+) Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2. Viruses, 13.","DOI":"10.3390\/v13081490"},{"key":"ref_15","unstructured":"Prokofyev, A., Gershovich, P., Strelkova, A., Spirina, N., Kondinskaya, D., Yakovlev, P., and Morozov, D. (2021). AAV5-Based Vaccine for Induction of Specific Immunity to SARS-CoV-2 Virus and\/or Prevention of SARS-CoV-2-Induced Coronavirus Infection. (RU 2761879 C1), Patent."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: Advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/03602549108021408","article-title":"Immobilized Metal Ion Affinity Chromatography (IMAC) Chemistry and Bioseparation Applications","volume":"20","author":"Wong","year":"1991","journal-title":"Sep. Purif. Methods"},{"key":"ref_18","unstructured":"(2022, June 27). Mascot Search Engine|Protein Identification Software for Mass Spec Data, (n.d.). Available online: http:\/\/www.matrixscience.com\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1002\/cpmc.108","article-title":"An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening","volume":"58","author":"Amanat","year":"2020","journal-title":"Curr. Protoc. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijid.2020.07.024","article-title":"Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak","volume":"99","author":"Kozlovskaya","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.17816\/MAJ76053","article-title":"Comparing of level of circulation of respiratory viruses during epidemic seasons 2015\u20132020 and COVID-19 pandemic in Saint Petersburg","volume":"21","author":"Ksenafontov","year":"2021","journal-title":"Med. Acad. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"001692","DOI":"10.1099\/jgv.0.001692","article-title":"Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples","volume":"102","author":"Szymczak","year":"2021","journal-title":"J. Gen. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Turkkan, A., Saglik, I., Turan, C., Sahin, A., Akalin, H., Ener, B., Kara, A., Celebi, S., Sahin, E., and Hacimustafaoglu, M. (2022). Nine-month course of SARS-CoV-2 antibodies in individuals with COVID-19 infection. Ir. J. Med. Sci.","DOI":"10.1007\/s11845-021-02716-x"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kudryavtsev, I., Rubinstein, A., Golovkin, A., Kalinina, O., Vasilyev, K., Rudenko, L., and Isakova-Sivak, I. (2022). Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses, 14.","DOI":"10.3390\/v14051082"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Tutukina, M., Kaznadzey, A., Kireeva, M., and Mazo, I. (2021). IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases. Viruses, 13.","DOI":"10.3390\/v13101945"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"584251","DOI":"10.3389\/fmicb.2020.584251","article-title":"Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals","volume":"11","author":"Brochot","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jmv.27420","article-title":"Evaluation of antibody response after COVID-19 vaccination of healthcare workers","volume":"94","author":"Uysal","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41591-022-01721-6","article-title":"Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines","volume":"28","author":"Wei","year":"2022","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2021.09.065","article-title":"Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers","volume":"113","author":"Heyming","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ay\u00f3n-N\u00fa\u00f1ez, D.A., Cervantes-Torres, J., Cabello-Guti\u00e9rrez, C., Rosales-Mendoza, S., Rios-Valencia, D., Huerta, L., Bobes, R.J., Carrero, J.C., Segura-Vel\u00e1zquez, R., and Fierro, N.A. (2022). An RBD-Based Diagnostic Method Useful for the Surveillance of Protective Immunity against SARS-CoV-2 in the Population. Diagnostics, 12.","DOI":"10.3390\/diagnostics12071629"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s15010-020-01503-7","article-title":"A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization","volume":"49","author":"Peterhoff","year":"2021","journal-title":"Infection"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"618097","DOI":"10.3389\/fmicb.2020.618097","article-title":"Development of a Fast SARS-CoV-2 IgG ELISA, Based on Receptor-Binding Domain, and Its Comparative Evaluation Using Temporally Segregated Samples From RT-PCR Positive Individuals","volume":"11","author":"Mehdi","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s43856-021-00012-4","article-title":"Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults","volume":"1","author":"Wagner","year":"2021","journal-title":"Commun. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1038\/s41467-021-24435-8","article-title":"Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies","volume":"12","author":"Greaney","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Bozdaganyan, M.E., Shaitan, K.V., Kirpichnikov, M.P., Sokolova, O.S., and Orekhov, P.S. (2022). Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding. Viruses, 14.","DOI":"10.3390\/v14020295"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"693775","DOI":"10.3389\/fimmu.2021.693775","article-title":"Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies","volume":"12","author":"Ding","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41467-021-27649-y","article-title":"Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents","volume":"13","author":"Koerber","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e03442-21","DOI":"10.1128\/mbio.03442-21","article-title":"Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time","volume":"13","author":"Sanchez","year":"2022","journal-title":"mBio"},{"key":"ref_40","first-page":"100123","article-title":"Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucuman, Argentina","volume":"6","author":"Chahla","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.vaccine.2021.12.027","article-title":"Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort","volume":"40","author":"Blanco","year":"2022","journal-title":"Vaccine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00647-20","DOI":"10.1128\/JVI.00647-20","article-title":"The Nucleocapsid Protein of SARS-CoV-2: A Target for Vaccine Development","volume":"94","author":"Dutta","year":"2020","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"815389","DOI":"10.3389\/fmed.2022.815389","article-title":"SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines","volume":"9","author":"Thakur","year":"2022","journal-title":"Front. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Paul, G., Strnad, P., Wienand, O., Krause, U., Plecko, T., Effenberger-Klein, A., Giel, K.E., Junne, F., Galante-Gottschalk, A., and Ehehalt, S. (2022). The humoral immune response more than one year after SARS-CoV-2 infection: Low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA. Infection.","DOI":"10.1007\/s15010-022-01830-x"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/9\/2041\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:31:22Z","timestamp":1760142682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/9\/2041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":44,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["v14092041"],"URL":"https:\/\/doi.org\/10.3390\/v14092041","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]}}}